ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Solid Organ Transplantation Rejection (SOT) Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-11P17520
Home | Market Reports | Health| Nursing
Global Solid Organ Transplantation Rejection SOT Market Research Report 2024
BUY CHAPTERS

Global Solid Organ Transplantation Rejection (SOT) Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-11P17520
Report
November 2025
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Terumo
Roche
Astellas Pharma
Preservation Solutions
Transmedic
Pfizer Inc
Sanofi
Veloxis Pharmaceuticals

Solid Organ Transplantation Rejection (SOT) Market

The global Solid Organ Transplantation Rejection (SOT) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Solid Organ Transplantation Rejection (SOT) leading manufacturers including Novartis, Terumo, Roche, Astellas Pharma, Preservation Solutions, Transmedic, Pfizer, Sanofi, Veloxis Pharmaceuticals, etc., dominate supply; the top five capture approximately % of global revenue, with Novartis leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Solid Organ Transplantation Rejection (SOT) market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Solid Organ Transplantation Rejection (SOT) Market Report

Report Metric Details
Report Name Solid Organ Transplantation Rejection (SOT) Market
Segment by Type
  • Kidney
  • Heart
  • Liver
Segment by Application
  • Hospital
  • Transplant Centers
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Terumo, Roche, Astellas Pharma, Preservation Solutions, Transmedic, Pfizer, Sanofi, Veloxis Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Solid Organ Transplantation Rejection (SOT) study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Solid Organ Transplantation Rejection (SOT) Market report?

Ans: The main players in the Solid Organ Transplantation Rejection (SOT) Market are Novartis, Terumo, Roche, Astellas Pharma, Preservation Solutions, Transmedic, Pfizer, Sanofi, Veloxis Pharmaceuticals

What are the Application segmentation covered in the Solid Organ Transplantation Rejection (SOT) Market report?

Ans: The Applications covered in the Solid Organ Transplantation Rejection (SOT) Market report are Hospital, Transplant Centers, Others

What are the Type segmentation covered in the Solid Organ Transplantation Rejection (SOT) Market report?

Ans: The Types covered in the Solid Organ Transplantation Rejection (SOT) Market report are Kidney, Heart, Liver

1 Study Coverage
1.1 Introduction to Solid Organ Transplantation Rejection (SOT): Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Solid Organ Transplantation Rejection (SOT) Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Kidney
1.2.3 Heart
1.2.4 Liver
1.3 Market Segmentation by Application
1.3.1 Global Solid Organ Transplantation Rejection (SOT) Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Transplant Centers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Solid Organ Transplantation Rejection (SOT) Revenue Estimates and Forecasts 2020-2031
2.2 Global Solid Organ Transplantation Rejection (SOT) Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Solid Organ Transplantation Rejection (SOT) Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Solid Organ Transplantation Rejection (SOT) Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Kidney Market Size by Players
3.3.2 Heart Market Size by Players
3.3.3 Liver Market Size by Players
3.4 Global Solid Organ Transplantation Rejection (SOT) Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Solid Organ Transplantation Rejection (SOT) Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Solid Organ Transplantation Rejection (SOT) Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Solid Organ Transplantation Rejection (SOT) Market Size by Type (2020-2031)
6.4 North America Solid Organ Transplantation Rejection (SOT) Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Solid Organ Transplantation Rejection (SOT) Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Solid Organ Transplantation Rejection (SOT) Market Size by Type (2020-2031)
7.4 Europe Solid Organ Transplantation Rejection (SOT) Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Solid Organ Transplantation Rejection (SOT) Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size by Type (2020-2031)
8.4 Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Solid Organ Transplantation Rejection (SOT) Market Size by Type (2020-2031)
9.4 Central and South America Solid Organ Transplantation Rejection (SOT) Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Solid Organ Transplantation Rejection (SOT) Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Solid Organ Transplantation Rejection (SOT) Market Size by Type (2020-2031)
10.4 Middle East and Africa Solid Organ Transplantation Rejection (SOT) Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Solid Organ Transplantation Rejection (SOT) Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Business Overview
11.1.3 Novartis Solid Organ Transplantation Rejection (SOT) Product Features and Attributes
11.1.4 Novartis Solid Organ Transplantation Rejection (SOT) Revenue and Gross Margin (2020-2025)
11.1.5 Novartis Solid Organ Transplantation Rejection (SOT) Revenue by Product in 2024
11.1.6 Novartis Solid Organ Transplantation Rejection (SOT) Revenue by Application in 2024
11.1.7 Novartis Solid Organ Transplantation Rejection (SOT) Revenue by Geographic Area in 2024
11.1.8 Novartis Solid Organ Transplantation Rejection (SOT) SWOT Analysis
11.1.9 Novartis Recent Developments
11.2 Terumo
11.2.1 Terumo Corporation Information
11.2.2 Terumo Business Overview
11.2.3 Terumo Solid Organ Transplantation Rejection (SOT) Product Features and Attributes
11.2.4 Terumo Solid Organ Transplantation Rejection (SOT) Revenue and Gross Margin (2020-2025)
11.2.5 Terumo Solid Organ Transplantation Rejection (SOT) Revenue by Product in 2024
11.2.6 Terumo Solid Organ Transplantation Rejection (SOT) Revenue by Application in 2024
11.2.7 Terumo Solid Organ Transplantation Rejection (SOT) Revenue by Geographic Area in 2024
11.2.8 Terumo Solid Organ Transplantation Rejection (SOT) SWOT Analysis
11.2.9 Terumo Recent Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Business Overview
11.3.3 Roche Solid Organ Transplantation Rejection (SOT) Product Features and Attributes
11.3.4 Roche Solid Organ Transplantation Rejection (SOT) Revenue and Gross Margin (2020-2025)
11.3.5 Roche Solid Organ Transplantation Rejection (SOT) Revenue by Product in 2024
11.3.6 Roche Solid Organ Transplantation Rejection (SOT) Revenue by Application in 2024
11.3.7 Roche Solid Organ Transplantation Rejection (SOT) Revenue by Geographic Area in 2024
11.3.8 Roche Solid Organ Transplantation Rejection (SOT) SWOT Analysis
11.3.9 Roche Recent Developments
11.4 Astellas Pharma
11.4.1 Astellas Pharma Corporation Information
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Solid Organ Transplantation Rejection (SOT) Product Features and Attributes
11.4.4 Astellas Pharma Solid Organ Transplantation Rejection (SOT) Revenue and Gross Margin (2020-2025)
11.4.5 Astellas Pharma Solid Organ Transplantation Rejection (SOT) Revenue by Product in 2024
11.4.6 Astellas Pharma Solid Organ Transplantation Rejection (SOT) Revenue by Application in 2024
11.4.7 Astellas Pharma Solid Organ Transplantation Rejection (SOT) Revenue by Geographic Area in 2024
11.4.8 Astellas Pharma Solid Organ Transplantation Rejection (SOT) SWOT Analysis
11.4.9 Astellas Pharma Recent Developments
11.5 Preservation Solutions
11.5.1 Preservation Solutions Corporation Information
11.5.2 Preservation Solutions Business Overview
11.5.3 Preservation Solutions Solid Organ Transplantation Rejection (SOT) Product Features and Attributes
11.5.4 Preservation Solutions Solid Organ Transplantation Rejection (SOT) Revenue and Gross Margin (2020-2025)
11.5.5 Preservation Solutions Solid Organ Transplantation Rejection (SOT) Revenue by Product in 2024
11.5.6 Preservation Solutions Solid Organ Transplantation Rejection (SOT) Revenue by Application in 2024
11.5.7 Preservation Solutions Solid Organ Transplantation Rejection (SOT) Revenue by Geographic Area in 2024
11.5.8 Preservation Solutions Solid Organ Transplantation Rejection (SOT) SWOT Analysis
11.5.9 Preservation Solutions Recent Developments
11.6 Transmedic
11.6.1 Transmedic Corporation Information
11.6.2 Transmedic Business Overview
11.6.3 Transmedic Solid Organ Transplantation Rejection (SOT) Product Features and Attributes
11.6.4 Transmedic Solid Organ Transplantation Rejection (SOT) Revenue and Gross Margin (2020-2025)
11.6.5 Transmedic Recent Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Solid Organ Transplantation Rejection (SOT) Product Features and Attributes
11.7.4 Pfizer Solid Organ Transplantation Rejection (SOT) Revenue and Gross Margin (2020-2025)
11.7.5 Pfizer Recent Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Solid Organ Transplantation Rejection (SOT) Product Features and Attributes
11.8.4 Sanofi Solid Organ Transplantation Rejection (SOT) Revenue and Gross Margin (2020-2025)
11.8.5 Sanofi Recent Developments
11.9 Veloxis Pharmaceuticals
11.9.1 Veloxis Pharmaceuticals Corporation Information
11.9.2 Veloxis Pharmaceuticals Business Overview
11.9.3 Veloxis Pharmaceuticals Solid Organ Transplantation Rejection (SOT) Product Features and Attributes
11.9.4 Veloxis Pharmaceuticals Solid Organ Transplantation Rejection (SOT) Revenue and Gross Margin (2020-2025)
11.9.5 Veloxis Pharmaceuticals Recent Developments
12 Solid Organ Transplantation Rejection (SOT)Industry Chain Analysis
12.1 Solid Organ Transplantation Rejection (SOT) Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Solid Organ Transplantation Rejection (SOT) Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Solid Organ Transplantation Rejection (SOT) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Novartis
Terumo
Roche
Astellas Pharma
Preservation Solutions
Transmedic
Pfizer Inc
Sanofi
Veloxis Pharmaceuticals
List of Tables
 Table 1. Global Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Solid Organ Transplantation Rejection (SOT) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Solid Organ Transplantation Rejection (SOT) Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Solid Organ Transplantation Rejection (SOT) Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Solid Organ Transplantation Rejection (SOT) Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Solid Organ Transplantation Rejection (SOT) by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Organ Transplantation Rejection (SOT) as of 2024)
 Table 11. Global Solid Organ Transplantation Rejection (SOT) Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Solid Organ Transplantation Rejection (SOT) Companies Headquarters
 Table 13. Global Solid Organ Transplantation Rejection (SOT) Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Solid Organ Transplantation Rejection (SOT) Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Solid Organ Transplantation Rejection (SOT) Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Solid Organ Transplantation Rejection (SOT) Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Solid Organ Transplantation Rejection (SOT) Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Solid Organ Transplantation Rejection (SOT) High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Solid Organ Transplantation Rejection (SOT) Growth Accelerators and Market Barriers
 Table 25. North America Solid Organ Transplantation Rejection (SOT) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Solid Organ Transplantation Rejection (SOT) Growth Accelerators and Market Barriers
 Table 27. Europe Solid Organ Transplantation Rejection (SOT) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Solid Organ Transplantation Rejection (SOT) Investment Opportunities and Key Challenges
 Table 31. Central and South America Solid Organ Transplantation Rejection (SOT) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Solid Organ Transplantation Rejection (SOT) Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Solid Organ Transplantation Rejection (SOT) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Novartis Corporation Information
 Table 35. Novartis Description and Major Businesses
 Table 36. Novartis Product Features and Attributes
 Table 37. Novartis Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Novartis Revenue Proportion by Product in 2024
 Table 39. Novartis Revenue Proportion by Application in 2024
 Table 40. Novartis Revenue Proportion by Geographic Area in 2024
 Table 41. Novartis Solid Organ Transplantation Rejection (SOT) SWOT Analysis
 Table 42. Novartis Recent Developments
 Table 43. Terumo Corporation Information
 Table 44. Terumo Description and Major Businesses
 Table 45. Terumo Product Features and Attributes
 Table 46. Terumo Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Terumo Revenue Proportion by Product in 2024
 Table 48. Terumo Revenue Proportion by Application in 2024
 Table 49. Terumo Revenue Proportion by Geographic Area in 2024
 Table 50. Terumo Solid Organ Transplantation Rejection (SOT) SWOT Analysis
 Table 51. Terumo Recent Developments
 Table 52. Roche Corporation Information
 Table 53. Roche Description and Major Businesses
 Table 54. Roche Product Features and Attributes
 Table 55. Roche Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Roche Revenue Proportion by Product in 2024
 Table 57. Roche Revenue Proportion by Application in 2024
 Table 58. Roche Revenue Proportion by Geographic Area in 2024
 Table 59. Roche Solid Organ Transplantation Rejection (SOT) SWOT Analysis
 Table 60. Roche Recent Developments
 Table 61. Astellas Pharma Corporation Information
 Table 62. Astellas Pharma Description and Major Businesses
 Table 63. Astellas Pharma Product Features and Attributes
 Table 64. Astellas Pharma Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Astellas Pharma Revenue Proportion by Product in 2024
 Table 66. Astellas Pharma Revenue Proportion by Application in 2024
 Table 67. Astellas Pharma Revenue Proportion by Geographic Area in 2024
 Table 68. Astellas Pharma Solid Organ Transplantation Rejection (SOT) SWOT Analysis
 Table 69. Astellas Pharma Recent Developments
 Table 70. Preservation Solutions Corporation Information
 Table 71. Preservation Solutions Description and Major Businesses
 Table 72. Preservation Solutions Product Features and Attributes
 Table 73. Preservation Solutions Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Preservation Solutions Revenue Proportion by Product in 2024
 Table 75. Preservation Solutions Revenue Proportion by Application in 2024
 Table 76. Preservation Solutions Revenue Proportion by Geographic Area in 2024
 Table 77. Preservation Solutions Solid Organ Transplantation Rejection (SOT) SWOT Analysis
 Table 78. Preservation Solutions Recent Developments
 Table 79. Transmedic Corporation Information
 Table 80. Transmedic Description and Major Businesses
 Table 81. Transmedic Product Features and Attributes
 Table 82. Transmedic Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Transmedic Recent Developments
 Table 84. Pfizer Corporation Information
 Table 85. Pfizer Description and Major Businesses
 Table 86. Pfizer Product Features and Attributes
 Table 87. Pfizer Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Pfizer Recent Developments
 Table 89. Sanofi Corporation Information
 Table 90. Sanofi Description and Major Businesses
 Table 91. Sanofi Product Features and Attributes
 Table 92. Sanofi Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Sanofi Recent Developments
 Table 94. Veloxis Pharmaceuticals Corporation Information
 Table 95. Veloxis Pharmaceuticals Description and Major Businesses
 Table 96. Veloxis Pharmaceuticals Product Features and Attributes
 Table 97. Veloxis Pharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Veloxis Pharmaceuticals Recent Developments
 Table 99. Raw Materials Key Suppliers
 Table 100. Distributors List
 Table 101. Market Trends and Market Evolution
 Table 102. Market Drivers and Opportunities
 Table 103. Market Challenges, Risks, and Restraints
 Table 104. Research Programs/Design for This Report
 Table 105. Key Data Information from Secondary Sources
 Table 106. Key Data Information from Primary Sources


List of Figures
 Figure 1. Solid Organ Transplantation Rejection (SOT) Product Picture
 Figure 2. Global Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Kidney Product Picture
 Figure 4. Heart Product Picture
 Figure 5. Liver Product Picture
 Figure 6. Global Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Hospital
 Figure 8. Transplant Centers
 Figure 9. Others
 Figure 10. Solid Organ Transplantation Rejection (SOT) Report Years Considered
 Figure 11. Global Solid Organ Transplantation Rejection (SOT) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Solid Organ Transplantation Rejection (SOT) Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Solid Organ Transplantation Rejection (SOT) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Region (2020-2031)
 Figure 15. Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share Ranking (2024)
 Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 17. Kidney Revenue Market Share by Player in 2024
 Figure 18. Heart Revenue Market Share by Player in 2024
 Figure 19. Liver Revenue Market Share by Player in 2024
 Figure 20. Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Type (2020-2031)
 Figure 21. Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Application (2020-2031)
 Figure 22. North America Solid Organ Transplantation Rejection (SOT) Revenue YoY (2020-2031) & (US$ Million)
 Figure 23. North America Top 5 Players Solid Organ Transplantation Rejection (SOT) Revenue (US$ Million) in 2024
 Figure 24. North America Solid Organ Transplantation Rejection (SOT) Revenue (US$ Million) by Type (2020 - 2031)
 Figure 25. North America Solid Organ Transplantation Rejection (SOT) Revenue (US$ Million) by Application (2020-2031)
 Figure 26. US Solid Organ Transplantation Rejection (SOT) Revenue (2020-2031) & (US$ Million)
 Figure 27. Canada Solid Organ Transplantation Rejection (SOT) Revenue (2020-2031) & (US$ Million)
 Figure 28. Mexico Solid Organ Transplantation Rejection (SOT) Revenue (2020-2031) & (US$ Million)
 Figure 29. Europe Solid Organ Transplantation Rejection (SOT) Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. Europe Top 5 Players Solid Organ Transplantation Rejection (SOT) Revenue (US$ Million) in 2024
 Figure 31. Europe Solid Organ Transplantation Rejection (SOT) Revenue (US$ Million) by Type (2020-2031)
 Figure 32. Europe Solid Organ Transplantation Rejection (SOT) Revenue (US$ Million) by Application (2020-2031)
 Figure 33. Germany Solid Organ Transplantation Rejection (SOT) Revenue (2020-2031) & (US$ Million)
 Figure 34. France Solid Organ Transplantation Rejection (SOT) Revenue (2020-2031) & (US$ Million)
 Figure 35. U.K. Solid Organ Transplantation Rejection (SOT) Revenue (2020-2031) & (US$ Million)
 Figure 36. Italy Solid Organ Transplantation Rejection (SOT) Revenue (2020-2031) & (US$ Million)
 Figure 37. Russia Solid Organ Transplantation Rejection (SOT) Revenue (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Top 8 Players Solid Organ Transplantation Rejection (SOT) Revenue (US$ Million) in 2024
 Figure 40. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Indonesia Solid Organ Transplantation Rejection (SOT) Revenue (2020-2031) & (US$ Million)
 Figure 43. Japan Solid Organ Transplantation Rejection (SOT) Revenue (2020-2031) & (US$ Million)
 Figure 44. South Korea Solid Organ Transplantation Rejection (SOT) Revenue (2020-2031) & (US$ Million)
 Figure 45. Australia Solid Organ Transplantation Rejection (SOT) Revenue (2020-2031) & (US$ Million)
 Figure 46. India Solid Organ Transplantation Rejection (SOT) Revenue (2020-2031) & (US$ Million)
 Figure 47. Indonesia Solid Organ Transplantation Rejection (SOT) Revenue (2020-2031) & (US$ Million)
 Figure 48. Vietnam Solid Organ Transplantation Rejection (SOT) Revenue (2020-2031) & (US$ Million)
 Figure 49. Malaysia Solid Organ Transplantation Rejection (SOT) Revenue (2020-2031) & (US$ Million)
 Figure 50. Philippines Solid Organ Transplantation Rejection (SOT) Revenue (2020-2031) & (US$ Million)
 Figure 51. Singapore Solid Organ Transplantation Rejection (SOT) Revenue (2020-2031) & (US$ Million)
 Figure 52. Central and South America Solid Organ Transplantation Rejection (SOT) Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Central and South America Top 5 Players Solid Organ Transplantation Rejection (SOT) Revenue (US$ Million) in 2024
 Figure 54. Central and South America Solid Organ Transplantation Rejection (SOT) Revenue (US$ Million) by Type (2020-2031)
 Figure 55. Central and South America Solid Organ Transplantation Rejection (SOT) Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Brazil Solid Organ Transplantation Rejection (SOT) Revenue (2020-2025) & (US$ Million)
 Figure 57. Argentina Solid Organ Transplantation Rejection (SOT) Revenue (2020-2025) & (US$ Million)
 Figure 58. Middle East and Africa Solid Organ Transplantation Rejection (SOT) Revenue YoY (2020-2031) & (US$ Million)
 Figure 59. Middle East and Africa Top 5 Players Solid Organ Transplantation Rejection (SOT) Revenue (US$ Million) in 2024
 Figure 60. South America Solid Organ Transplantation Rejection (SOT) Revenue (US$ Million) by Type (2020-2031)
 Figure 61. Middle East and Africa Solid Organ Transplantation Rejection (SOT) Revenue (US$ Million) by Application (2020-2031)
 Figure 62. GCC Countries Solid Organ Transplantation Rejection (SOT) Revenue (2020-2025) & (US$ Million)
 Figure 63. Israel Solid Organ Transplantation Rejection (SOT) Revenue (2020-2025) & (US$ Million)
 Figure 64. Egypt Solid Organ Transplantation Rejection (SOT) Revenue (2020-2025) & (US$ Million)
 Figure 65. South Africa Solid Organ Transplantation Rejection (SOT) Revenue (2020-2025) & (US$ Million)
 Figure 66. Solid Organ Transplantation Rejection (SOT) Industry Chain Mapping
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Organ Transplant Rejection Medicine Market Research Report 2025
Global Heart Transplant Rejection Treatment Market Research Report 2025
Global Kidney Transplant Rejection Therapeutics Market Research Report 2024
Global Solid Organ Transplant Immunosuppressant Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Kidney Transplant Anti Rejection Drugs Market Research Report 2024
Organ Transplant Rejection Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Organ Transplant Anti rejection Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Organ Preservation Technology Market Research Report 2025
Global Organ Transplant Immunosuppressant Drugs Market Insights Forecast to 2030
Global Organ Transport Device Market Research Report 2024
Global Transplantation Therapeutics Drugs Market Research Report 2024
Global 3D Bioprinted Organ Transplant Market Research Report 2024
Global Organ Preservation Device Market Research Report 2024
Global Gamete Transplantation Market Research Report 2024
Global Organ Transportation Service Market Research Report 2025
Organ Rejection Prophylaxis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Transplant Drug Concentration Monitoring Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Solid Aseptic Transfer System Market Research Report 2024
Global Organ Transport Service Market Research Report 2025
Global Fecal Microbiota Transplantation FMT Market Research Report 2025

RELATED REPORTS

Global Life Sciences IT Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-19E17259
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Rehabilitation Evaluation Equipment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-39U17029
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Modular Healthcare Buildings Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-24Y16719
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Digital Telepathology Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0S20450
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions